Amphastar Pharmaceuticals, Inc. (AMPH)
USD 39.45
(-3.43%)
USD 39.45
(-3.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 183.5 Million | 89.18 Million | 97.99 Million | 57.26 Million | 41.76 Million | 38.19 Million |
| Net Income | 137.54 Million | 91.38 Million | 63.3 Million | 1.09 Million | 46.5 Million | -6.66 Million |
| Depreciation & Amortization | 41.77 Million | 28.74 Million | 26.75 Million | 25.18 Million | 21.12 Million | 16.51 Million |
| Deferred income taxes | -12.57 Million | -15.75 Million | 4.2 Million | 1.12 Million | 7.55 Million | -1.87 Million |
| Stock-based compensation | 20.24 Million | 17.86 Million | 18.68 Million | 20.49 Million | 17.29 Million | 16.68 Million |
| Change in working capital | -24.2 Million | -32.17 Million | -1.92 Million | 9.12 Million | -51.74 Million | 12.1 Million |
| Other non-cash items | 20.72 Million | -878 Thousand | -13.03 Million | 240 Thousand | 1.03 Million | 1.42 Million |
| Investing Cash Flow | -649.11 Million | -32.77 Million | -28.67 Million | -36.41 Million | -50.52 Million | -42.18 Million |
| Investments in PPE | -38.16 Million | -24.03 Million | -27.45 Million | -33.85 Million | -41.55 Million | -46.8 Million |
| Acquisitions | -506.4 Million | 421 Thousand | - | - | - | 4.64 Million |
| Investment purchases | -144.55 Million | -35.76 Million | -17.37 Million | -13.55 Million | -8.81 Million | -308 Thousand |
| Sales/Maturities of investments | 38.62 Million | 27.96 Million | 18.77 Million | 12.41 Million | - | 91 Thousand |
| Other Investing Activities | 1.39 Million | -1.37 Million | -2.61 Million | -1.41 Million | -157 Thousand | 198 Thousand |
| Financing Cash Flow | 454.09 Million | -26.43 Million | -37.01 Million | -2.24 Million | -3.78 Million | 25 Million |
| Debt repayment | -501.26 Million | -1.78 Million | -37.9 Million | -8.4 Million | -6.78 Million | -5.7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -58.14 Million | -39.9 Million | -28.87 Million | -24.42 Million | -22.29 Million | -25.04 Million |
| Common Stock Issuance | 10.97 Million | 15.65 Million | 15.92 Million | 23.16 Million | 18.29 Million | 38.03 Million |
| Other Financing Activities | -25.07 Million | 15.25 Million | 29.75 Million | 30.58 Million | 6.99 Million | 38.03 Million |
| Accounts receivables | -26.08 Million | -10.13 Million | -14.92 Million | -20.16 Million | 6.7 Million | -16.29 Million |
| Accounts payables | 13.23 Million | -736 Thousand | 3.01 Million | 14.96 Million | -17.93 Million | 29.15 Million |
| Inventory | -1.72 Million | -11.74 Million | 1.25 Million | 15.29 Million | -41.1 Million | -5.98 Million |
| Other working capital | -9.63 Million | -9.56 Million | 8.72 Million | -972 Thousand | 591 Thousand | 5.22 Million |
| Cash at beginning of period | 156.33 Million | 126.58 Million | 94.5 Million | 75.55 Million | 88.2 Million | 67.45 Million |
| Cash at end of period | 144.53 Million | 156.33 Million | 126.58 Million | 94.5 Million | 75.55 Million | 88.2 Million |
| Capital Expenditure | -38.16 Million | -24.03 Million | -27.45 Million | -33.85 Million | -41.55 Million | -46.8 Million |
| Effect of forex changes on cash | -282 Thousand | -220 Thousand | -223 Thousand | 352 Thousand | -104 Thousand | -274 Thousand |
| Net cash flow / Change in cash | -11.8 Million | 29.74 Million | 32.08 Million | 18.95 Million | -12.65 Million | 20.74 Million |
| Free Cash Flow | 145.33 Million | 65.14 Million | 70.53 Million | 23.41 Million | 207 Thousand | -8.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 37.94 Million | 43.17 Million | 36.16 Million | 137.54 Million | 49.22 Million | 26.12 Million |
| Depreciation & Amortization | 14.14 Million | 13.96 Million | 13.78 Million | 41.77 Million | 13.57 Million | 7.02 Million |
| Deferred income taxes | - | - | -12.57 Million | -12.57 Million | -2.59 Million | 11.49 Million |
| Stock-based compensation | 5.78 Million | 7.36 Million | 4.62 Million | 20.24 Million | 4.64 Million | 4.86 Million |
| Change in working capital | 8.63 Million | -7.26 Million | -26.74 Million | -24.2 Million | -5.74 Million | 8.41 Million |
| Other non-cash items | 23.29 Million | 43.46 Million | 8.6 Million | 20.72 Million | 5.23 Million | -2.99 Million |
| Investing Cash Flow | -69.9 Million | 15.23 Million | -103.04 Million | -649.11 Million | -31.15 Million | -508.58 Million |
| Investments in PPE | -6.04 Million | -8.79 Million | -9.44 Million | -38.16 Million | -10.19 Million | -9.05 Million |
| Acquisitions | -129 Million | - | 506.4 Million | -506.4 Million | -5.57 Million | -500.82 Million |
| Investment purchases | 960 Thousand | -22.5 Million | -91.75 Million | -144.55 Million | -33.02 Million | -9.2 Million |
| Sales/Maturities of investments | 65.77 Million | 47.49 Million | -179 Thousand | 38.62 Million | 13.65 Million | 11.08 Million |
| Other Investing Activities | -636 Thousand | -960 Thousand | -1.67 Million | 1.39 Million | 3.99 Million | -586 Thousand |
| Financing Cash Flow | -10.71 Million | -13.57 Million | -47.08 Million | 454.09 Million | 86.61 Million | 428.11 Million |
| Debt repayment | -8.03 Million | -3.73 Million | -50.64 Million | -501.26 Million | -134.48 Million | -418.38 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -8.49 Million | -17.31 Million | 58.14 Million | -58.14 Million | -50 Million | -128 Thousand |
| Common Stock Issuance | 5.81 Million | -17.31 Million | 3.56 Million | 10.97 Million | 2.12 Million | 9.85 Million |
| Other Financing Activities | 1000.00 | -252 Thousand | -491 Thousand | -25.07 Million | -10.43 Million | 428.11 Million |
| Accounts receivables | 6.67 Million | -23.2 Million | 4.08 Million | -26.08 Million | -19.64 Million | 1.26 Million |
| Accounts payables | 13.72 Million | 23.07 Million | -3.38 Million | 13.23 Million | 6.45 Million | 2.68 Million |
| Inventory | -7.02 Million | -9.99 Million | 4.81 Million | -1.72 Million | -5.77 Million | -1.03 Million |
| Other working capital | -4.74 Million | 2.85 Million | -32.25 Million | -9.63 Million | 13.21 Million | 5.5 Million |
| Cash at beginning of period | 201.38 Million | 144.53 Million | 271.03 Million | 156.33 Million | 151.28 Million | 176.85 Million |
| Cash at end of period | 189.85 Million | 201.38 Million | 144.53 Million | 144.53 Million | 271.03 Million | 151.28 Million |
| Capital Expenditure | -6.04 Million | -8.79 Million | -9.44 Million | -38.16 Million | -10.19 Million | -9.05 Million |
| Effect of forex changes on cash | -19 Thousand | -97 Thousand | -238 Thousand | -282 Thousand | -38 Thousand | -22 Thousand |
| Net cash flow / Change in cash | -11.52 Million | 56.85 Million | -126.5 Million | -11.8 Million | 119.75 Million | -25.57 Million |
| Free Cash Flow | 63.06 Million | 46.49 Million | 14.42 Million | 145.33 Million | 54.14 Million | 45.86 Million |
TETOF
BSKZF
PRO
027410
104700
MOS